| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.008 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.01 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | IOX2 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.01 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.01 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.02 |